Logo.jpg
Tiger Nuts Market To Reach USD 371.7 Million By 2032 | DataHorizzon Research
May 04, 2024 09:00 ET | DataHorizzon Research
Fort Collins, Colorado, May 04, 2024 (GLOBE NEWSWIRE) -- The growing importance of tiger nuts drives market demand. Increasing awareness of the nutritional value of tiger nuts is a significant...
Logo.jpg
Trifluoroacetic Acid Market To Reach USD 459.4 Million By 2032 | DataHorizzon Research
May 04, 2024 08:00 ET | DataHorizzon Research
Fort Collins, Colorado, May 04, 2024 (GLOBE NEWSWIRE) -- The versatility of trifluoroacetic acid drives industry developments. The market growth of trifluoroacetic acid (TFA) is propelled by its...
MnM_logo_TM_JPG.JPG
Market for Functional Food Ingredients Industry is Booming on Health and Wellness Trends
May 03, 2024 09:30 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, May 03, 2024 (GLOBE NEWSWIRE) -- Functional food ingredients are bioactive compounds that are added to food or beverages to promote health benefits beyond basic nutrition. These ingredients...
VMR Logo.png
Molecular Biology Enzymes And Kits And Reagents Market Surges to USD 69.4 Billion by 2031, Propelled by 17.35% CAGR - Verified Market Research®
May 02, 2024 10:00 ET | Verified Market Research
Lewes, Delaware, May 02, 2024 (GLOBE NEWSWIRE) -- The Global Molecular Biology Enzymes And Kits And Reagents Market is projected to grow at a CAGR of 17.35% from 2024 to 2031, according to a new...
XWELL_Black_CMYK.jpg
XpresSpa Introduces IV Hydration Drip Therapy at Miami International Airport
May 02, 2024 08:00 ET | XWELL, Inc.
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), an authority in wellness solutions for people on the go, today announced the introduction of IV...
HyberCell.jpg
HiberCell Announces First Patient Dosed in Clinical Collaboration with Merck, Evaluating HC-7366 in Combination with WELIREG® (belzutifan) in patients with advanced ccRCC
May 01, 2024 17:00 ET | HiberCell, Inc.
HiberCell Announces FPD in Clinical Collaboration with Merck, Evaluating HC-7366 in Combination with WELIREG® (belzutifan) in patients with ccRCC
MG-Logo-Lockup B-Spruce.png
Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
May 01, 2024 16:00 ET | Metagenomi, Inc.
EMERYVILLE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its...
download.png
Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation
May 01, 2024 08:47 ET | Altamira Therapeutics Ltd
Hamilton, Bermuda, May 01, 2024 (GLOBE NEWSWIRE) -- Continued expansion of IP portfolio related to RNA delivery  Treatment of rheumatoid arthritis as one of the key therapeutic indications ...
Aileron-logo.png
Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)
May 01, 2024 08:30 ET | Aileron Therapeutics, Inc.
Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both pathological basal-like cells and fibroblasts and increased the expression of a...
Sphinx Code Taps Into the Power of Algorithm, Unveils the Archetypal Blueprint® That Guides You Through Personal Growth
April 30, 2024 14:32 ET | Sphinx Code
Houston, Texas, April 30, 2024 (GLOBE NEWSWIRE) -- The rise of spiritual awareness inspired an outflux of holistic methods that steer people through the mystical seas of self-discovery. With a...